Growth Hormone for Gastroparesis
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team to understand any specific requirements.
Is growth hormone generally safe for humans?
Growth hormone has been used for over 40 years and is considered to have a wide safety margin, with few adverse events reported. Some side effects like swelling, increased blood sugar, and bone issues require monitoring, but there is no evidence it increases cancer risk. Long-term safety is still being studied, especially regarding mortality and stroke risk.12345
How does the drug Growth Hormone differ from other treatments for gastroparesis?
Growth Hormone is unique for gastroparesis as it is primarily used to stimulate growth hormone release, which is different from typical treatments that focus on managing symptoms like nausea and delayed stomach emptying. This approach may offer a novel way to address underlying issues rather than just symptoms.678910
What data supports the effectiveness of the drug Growth Hormone for treating gastroparesis?
Who Is on the Research Team?
Tisha Lunsford
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for individuals with gastroparesis, a condition that affects stomach emptying, who haven't improved after standard treatments. Participants must have had symptoms for over 6 months and score above 21 on the Gastroparesis Cardinal Symptom Index. Exclusions include thyroid issues, heart diseases, obesity, pregnancy, certain hormonal therapies or conditions, and past growth hormone therapy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Growth Hormone treatment to assess symptomatic improvement in gastroparesis
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Growth Hormone
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor